An observational study in Atrial Fibrillation, Coronary Artery Disease and Aortic Valve Stenosis, sponsored by University of Turku. Active, not recruiting at 1 site in Finland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-05-08.
Sponsored by University of Turku · Observational
Among 11 studies in Atrial Fibrillation by University of Turku — 1 open to participants now, 3 under way, none of them phase 3. Atrial Fibrillation · University of Turku.
Among the 11 studies in Atrial Fibrillation by University of Turku, this one is one of 2 that started in 2016, is one of 9 observational ones, and was the 7th registered.
4,009 studies on the registry are indexed under Atrial Fibrillation; 961 are open to participants now.
Browse Atrial Fibrillation studies →1 of the 11 studies in Atrial Fibrillation by University of Turku is open now, in 1 country. Recruiting first, the newest first:
University of Turku · Sites in Finland
By country, each count listing its studies:
Of the 612 Atrial Fibrillation studies recruiting now, 407 (67%) set no upper age limit and 44 (7%) stop at 75 or younger; 21 take children under 18; 43 take healthy volunteers.
This study: 18 Years and older · all sexes.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
11 studies; the count open now beside each. This study's row is marked.
First in 2002; this study’s year is marked. 2 started in 2016.
This study's enrollment of 1,001 is above the median of 300 across 1,400 observational studies indexed under Atrial Fibrillation.
Median enrollment 175 across the 2 interventional studies, 1,001 across the 9 observational. Of the 7 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of Turku is the lead sponsor of 122 studies on the registry; 16 are open to participants now.
2 of the studies in Atrial Fibrillation by University of Turku that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07148934University of TurkuValidity and Algorithm Development for Detection of Supraventricular Tachycardia in Children-A Clinical Pilot Study | 2026-12 |
| NCT03444259University of TurkuProspective Project to Identify Biomarkers of Morbidity and Mortality in Cardiovascular Interventional Patients | 2026-12-31 |
Among the 11 studies in Atrial Fibrillation by University of Turku, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The objective of CAREBANK study is to establish definitive relationships with human cardiac samples and clinical phenotypes in patients undergoing cardiac procedures. Specifically, the investigators aim at comparing atrial phenotypes from atrial fibrillation patients and controls. The work consists of three broad categories: A) role of atrial cardiomyopathy in atrial fibrillation; B) genetic defects predisposing to atrial fibrillation; and C) the role of inflammation in atrial fibrillation.
The investigators aim to A) compare atrial cardiomyopathy findings from the tissue samples to clinical phenotype and adverse events B) study the association of genetic defects predisposing to atrial fibrillation with atrial cardiomyopathy findings in the tissue samples C) assess the role of inflammation in atrial fibrillation by comparing circulating cytokine profiles, purinergic signaling and atrial cardiomyopathy findings in tissue samples.
Consecutive patients undergoing open-heart cardiac surgery
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients with atrial fibrillation
Procedure: Cardiac surgery
Patients undergoing coronary bypass
Procedure: Cardiac surgery
Patients undergoing aortic valve replacement
Procedure: Cardiac surgery
Patients undergoing mitral valve repair
Procedure: Cardiac surgery
Patients undergoing cardiac surgery for indication other than above
Procedure: Cardiac surgery
Open heart surgery
Atrial fibrillation
Occurrence of atrial fibrillation
Time frame: postoperatively until 5 years follow-up
Stroke
Occurrence of stroke
Time frame: postoperatively until 5 years follow-up
Transient ischemic attack
Occurrence of Transient ischemic attack
Time frame: postoperatively until 5 years follow-up
Myocardial infarction
Occurrence of Myocardial infarction
Time frame: postoperatively until 5 years follow-up
Target vessel revascularization
Occurrence of Target vessel revascularization
Time frame: postoperatively until 5 years follow-up
All-cause Mortality
All-cause Mortality
Time frame: postoperatively until 5 years follow-up
Post-pericardiotomy syndrome
Occurrence of Post-pericardiotomy syndrome
Time frame: postoperatively until 1 years follow-up
Plan to share: Undecided
Started Feb 2016 (actual). Primary completion is estimated for Dec 2026, 130 months after the start.
Of 550 non-industry observational studies under Atrial Fibrillation, half reached primary completion within 46 months of starting (the median), counting those still running; a quarter within 25 and three quarters within 91. This study's planned 130 months is above that.
Counting every sponsor, half of 698 studies reached it within 38 months; a quarter within 22 and three quarters within 76.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in May 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.